VistaGen, WARF Sign License Agreement for Human Embryonic Stem Cell Technology
Thursday, December 18, 2008 - 18:28
in Biology & Nature
VistaGen Therapeutics and the Wisconsin Alumni Research Foundation (WARF) have signed a license for human embryonic stem cell patents for the development and commercialization of stem cell-based research tools.
Read the whole article on Newswise - Scinews
More from Newswise - Scinews
Related
- Human embryonic stem cell secretions minimized tissue injury after heart attackWed, 10 Sep 2008, 9:57:02 EDT
- New layer of control over human embryonic stem cells foundThu, 30 Apr 2009, 13:16:30 EDT
- First reconstitution of an epidermis from human embryonic stem cellsThu, 19 Nov 2009, 19:29:56 EST
- Motor neurons derived from human embryonic stem cells provide insight into ALSWed, 3 Dec 2008, 12:38:19 EST
- Leukemia stem cells have more in common with embryonic stem cells than adult stem cellsThu, 5 Feb 2009, 12:45:38 EST